TechNavio today launched its Anti-cancer Drugs Market in Japan 2011“2015 report based on an in-depth study focusing exclusively on the Japanese market. The report aims to aid decision makers™ understanding of the present and the future landscape of the market.
Commenting on the report, an analyst from TechNavio™s Healthcare team said, Poor awareness of cancer and its prevention among people and consequent late stage detection of most cancers in patients is quite common in Japan. Healthcare systems in Asia have recognized this problem and are working to educate the public on the causes of cancer, as well as to improve their facilities for treating the disease. For instance, Eisai has established a Japan-based oncology promotion framework, under which oncology information specialists have been assigned to each prefecture in the case of japan and approximately 1,400 medical representatives have been stationed around the country to provide information on anti-cancer therapies.
According to the report, the Pharmaceutical market in Japan differs noticeably from western markets in several aspects of the regulatory areas for the approval of drugs, and it continues to undergo significant changes. In Japan, both regional and global vendors have to undergo a long and rigorous process for approvals and licenses to market.
The report also reveals that one of the major challenges in this market is the presence of counterfeit anti-cancer drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/anti-cancer-drugs-market-japan-2011-2015
Follow us on Twitter @ Technavioƒ
TechNavio Announces the Publication of its Report “ Anti-cancer Drugs Market in Japan 2011“2015
